These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25470815)

  • 1. Combining biologics with methotrexate in psoriasis: a systematic review.
    van Bezooijen JS; Prens EP; Pradeepti MS; Atiqi R; Schreurs MWJ; Koch BCP; van Gelder T; van Doorn MBA
    Br J Dermatol; 2015 Jun; 172(6):1676-1680. PubMed ID: 25470815
    [No Abstract]   [Full Text] [Related]  

  • 2. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence among patients with psoriasis on traditional systemic and biologics treatment.
    Hambly R; Kelly A; Gilhooley E; Nic Dhonncha E; Murad A; Hughes R; Lally A; Kirby B
    Br J Dermatol; 2018 Jan; 178(1):e46-e48. PubMed ID: 28762482
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
    J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis Patients Treated With Biologics and Methotrexate Have a Reduced Rate of Myocardial Infarction: A Collaborative Analysis Using International Cohorts.
    Gulliver WP; Young HM; Bachelez H; Randell S; Gulliver S; Al-Mutairi N
    J Cutan Med Surg; 2016 Nov; 20(6):550-554. PubMed ID: 27402717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
    Busard CI; Cohen AD; Wolf P; Gkalpakiotis S; Cazzaniga S; Stern RS; Hutten BA; Feldhamer I; Quehenberger F; Lichem R; Kojanova M; Adenubiova E; Addis A; Naldi L; Spuls PI
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching biologics in severe pediatric psoriasis: a retrospective analysis.
    Ramos Pinheiro R; Diamantino F; Cabete J; Brasileiro A; Baptista J; Lopes MJP
    Int J Dermatol; 2017 Dec; 56(12):1461-1464. PubMed ID: 28960270
    [No Abstract]   [Full Text] [Related]  

  • 8. Practical experience of biologics for treatment of very severe psoriasis: a retrospective case cohort study of patients with a baseline Psoriasis Area and Severity Index greater than 20.
    Ponnambath N; Kalavala M; Anstey AV; Piguet V; Ingram JR
    Clin Exp Dermatol; 2016 Jan; 41(1):95-6. PubMed ID: 25817265
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical Strategies for Optimizing Management of Psoriasis.
    Wu JJ; Armstrong AW; Gordon KB; Menter MA
    Semin Cutan Med Surg; 2018 Feb; 37(2S):S52-S55. PubMed ID: 29614139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of biologics with traditional agents in psoriasis.
    Guenther LC
    Skin Therapy Lett; 2011 Jun; 16(6):1-3. PubMed ID: 21833461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
    Warren RB; Brown BC; Carmichael AJ; Griffiths CE
    Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete reversion of anti-infliximab immunization by methotrexate combination in a patient with psoriasis.
    Vincent T; Best M; Plawecki M; Girard C
    J Dermatol; 2015 Oct; 42(10):1030-1. PubMed ID: 26119228
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists.
    Pink AE; Smith CH
    Br J Dermatol; 2017 Jul; 177(1):7-8. PubMed ID: 28731243
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of biologics and other systemic agents in the treatment of pediatric psoriasis.
    Wright NA; Piggott CD; Eichenfield LF
    Semin Cutan Med Surg; 2010 Mar; 29(1):20-7. PubMed ID: 20430304
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-tuberculous mycobacterial infections in psoriasis patients treated with biologics.
    Choi YM; Adelzadeh L; Wu JJ
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e99-e101. PubMed ID: 26388307
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group.
    Nikolaou V; Sibaud V; Fattore D; Sollena P; Ortiz-Brugués A; Giacchero D; Romano MC; Riganti J; Lallas K; Peris K; Voudouri D; Lallas A; Fabbrocini G; Lazaridou E; Carrera C; Annunziata MC; Rossi E; Patri A; Rigopoulos D; Stratigos AJ; Apalla Z
    J Am Acad Dermatol; 2021 May; 84(5):1310-1320. PubMed ID: 33279646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Biologic Therapies Sometimes Lose Efficacy.
    Strober BE
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S78-80. PubMed ID: 27525443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis in the mature patient: Therapeutic approach in the era of biologics.
    Kostović K; Žužul K; Čeović R; Bukvić Mokos Z
    Clin Dermatol; 2018; 36(2):222-230. PubMed ID: 29566926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal for long-term protocols after Psoriasis Area and Severity Index clear with initial biologic therapy: Happily ever after with or without biologics in psoriasis therapy.
    Sano S
    J Dermatol; 2017 Oct; 44(10):e234-e235. PubMed ID: 28623843
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
    Heikkilä H; Ranki A; Cajanus S; Karvonen SL
    Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.